SF3A2

Splicing factor 3A subunit 2 · Q15428 · SF3A2 on Sugi Atlas →

0 patent compounds predicted against SF3A2, 0 high-confidence (nearest known ligand ≥ 0.5)

Top predicted compounds (top 20 by supporting neighbours, then confidence)

CompoundConfidenceSupporting neighbours

Clinical trials — most relevant to SF3A2 by text similarity (a relevance ranking, not an exhaustive list)

TrialPhaseStatus
Valproate and Levocarnitine in Children With Spinal Muscular Atrophy PHASE3UNKNOWN
Enzalutamide and Cabazitaxel in Treating Patients With Metastatic, Castration-Resistant Prostate Cancer PHASE1/PHASE2ACTIVE_NOT_RECRUITING
New Treatment Strategies and Epigenetic Biomarker for Management of Benign Prostatic Hyperplasia PHASE2RECRUITING
AAV9 U7snRNA Gene Therapy to Treat Boys With DMD Exon 2 Duplications. PHASE1/PHASE2COMPLETED
Role of SF3B1 Mutation in Assessment of Acute and Chronic Lymphatic Leukemia nanNOT_YET_RECRUITING
Biocollection in MyeloDysplastic Syndrome (P-MDS) nanRECRUITING
Molecular Disease Profile of Hematological Malignancies nanUNKNOWN
Personalized Medicine Program on Myelodysplastic Syndromes: Characterization of the Patient's Genome for Clinical Decision Making and Systematic Collection of Real World Data to Improve Quality of Health Care nanCOMPLETED
SRSF2 Gene Mutation in Patients With t-MDS/AML nanCOMPLETED
Association of SNPs in Long Intergenic Noncoding RNA 00511 (LINC00511) With Breast Cancer Among the Egyptian Population nanCOMPLETED
Clinical Study of Spinal Muscular Atrophy nanCOMPLETED
Mechanisms of Cell Death in Spinal Muscular Atrophy nanCOMPLETED
Patient's Derived Organoids for Drug Screening in Glioblastoma nanNOT_YET_RECRUITING
Becker Muscular Dystrophy - A Natural History Study to Predict Efficacy of Exon Skipping nanUNKNOWN
Outcome Measures and Biomarkers in a Cohort of Spinal Muscular Atrophy Type III/ IV Patients nanACTIVE_NOT_RECRUITING
MiRNA223 and HMGB1 as Apredictos for Drug Resistant Epilepsy nanUNKNOWN
Genomic Services Research Program nanRECRUITING
Efficacy and Safety Study of EGCG/Tocotrienol in 18 Patients With Splicing-mutation-mediated Cystic Fibrosis (CF) nanCOMPLETED
Prevalence of a Non-Expressing 11B Mutation in Aka Peoples of the Central African Republic nanCOMPLETED
GENOMED4ALL: Improving MDS Classification and Prognosis by AI nanUNKNOWN
SMN Circular RNAs as Potential Biomarkers for the Therapeutic Response to Nusinersen in Spinal Muscular Atrophy Patients nanUNKNOWN
Pharmacogenomic Association Study in Indian Children With Acute Lymphoblastic Leukemia nanRECRUITING
Aberrant Splicings Due to Microsatellite Instability in Colorectal Cancer : Physiopathological and Clinical Impact nanUNKNOWN
New Imaging Biomarkers for Muscular Diseases - Multispectral Optoacoustic Imaging in Spinal Muscular Atrophy nanCOMPLETED
Evaluation of Therapeutic Response in Spinal Muscular Atrophy Using Multispectral Optoacoustic Tomography (MSOT) and Magnetic Resonance Imaging (MRI) nanUNKNOWN
RNA Sequencing in the Framingham Heart Study Third Generation Cohort Exam 2 nanCOMPLETED
Brain Involvement in Myotonic Dystrophy Type I: From Functional Neuroimaging to the Impact on Quality of Life nanCOMPLETED
Genetic Factors Affecting the Severity of Beta Thalassemia nanCOMPLETED
MicroRNA-1 (miRNA-1) and MicroRNA-133a (miRNA-133a) Levels After Acute Exercise in Ultimate Frisbee Athletes nanUNKNOWN
LINC00511/miR-185-3p Axis and miR-301a-3p Markers for Breast Cancer Diagnosis nanCOMPLETED

Related proteins — ESM-2 sequence neighbours (a SF3A2 binder may also engage these)

ProteinNameSimilarity
Q6AXT8 1.000 Q6AXT8 →
A5PJN8 1.000 A5PJN8 →
Q62203 1.000 Q62203 →
Q63627 0.991 Q63627 →
Q9R0I7 0.986 Q9R0I7 →
P0CB49 0.986 P0CB49 →
O95104 0.986 O95104 →
Q7TSH6 0.984 Q7TSH6 →
Q9LV14 0.984 Q9LV14 →
Q7TN99 0.983 Q7TN99 →
PPP1R10 Serine/threonine-protein phosphatase 1 regulatory subunit 10 0.983 landscape →
Q8N693 0.983 Q8N693 →
Q767K9 0.981 Q767K9 →
P97868 0.981 P97868 →
Q9ESU6 0.981 Q9ESU6 →
Q9UPN6 0.981 Q9UPN6 →
Q9JIY2 0.981 Q9JIY2 →
Q95XQ1 0.981 Q95XQ1 →
Q6DRG1 0.981 Q6DRG1 →
Q4R7I8 0.981 Q4R7I8 →
SETD1B Histone-lysine N-methyltransferase SETD1B 0.980 landscape →
Q80TZ9 0.980 Q80TZ9 →
F1R5H6 0.980 F1R5H6 →
Q5TM61 0.980 Q5TM61 →
G3CHK5 0.980 G3CHK5 →
Q66J90 0.980 Q66J90 →
P49750 0.980 P49750 →
Q62901 0.980 Q62901 →
P34545 0.979 P34545 →
Q8CFT2 0.979 Q8CFT2 →